Vendor products
Live, browser-based, interactive ultrasound allows doctors and technicians to confer with colleagues with high definition imaging to ensure a timely diagnosis. May 21, 2014- Melville, NY- Remote Medical Technologies’ iMedHD2™...
The US Food and Drug Administration recently approved the use of a human papillomavirus (HPV) test as a primary cervical cancer screening test in women as young as 25 years, yet physicians are unlikely to ditch the Papanicolaou (Pap) test soon,...
Presenters: Dr. Bernard Fox, Endowed Chair and Chief, Laboratory of Molecular and Tumor Immunology Providence Cancer Center Dr. Carlo Bifulco, Director of Molecular Pathology and Pathology Informatics Providence Regional...
Unprecedented Healthcare Change Healthcare is currently undergoing more change than we have seen in decades. With the Patient Protection and Affordable Care Act (PPACA), Meaningful Use, ICD-10, and numerous other regulatory changes...
Formation of strategic alliance designed to help accelerate advancement of new methods in molecular diagnostics testing and personalized predictive treatment INDIANAPOLIS, May 20, 2014 /PRNewswire/ -- Roche...
Hørsholm, Denmark -- Today, the Market Development Fund, announced that it will support Visiopharm’s validation of its novel solutions for cancer diagnostics at seven Danish Hospitals and three international Hospitals. Visiopharm’s...
